Pharmafile Logo
Pharmafocus logo
Advanced Search
fda

Biosimilars: Can the US catch up in 2016?

February 12, 2016
Medical Communications, Sales and Marketing Eli Lilly, Enbrel, FDA, Neulasta, Novartis, Pfizer, Sandoz, Zarxio, biosimilars

What are biosimilars? Biosimilars are essentially the biological equivalent of generic drugs to their branded small-molecule counterparts (what Ibuprofen is …

Feature
gsk_good_smaller

GSK fined millions over deals to delay generic competition

February 12, 2016
Medical Communications, Sales and Marketing GSK seroxat

GlaxoSmithKline has been fined £37.6m by the UK Competition & Markets Authority (CMA) for paying two generic drugmakers to delay …

News
sandoz_good

Sandoz buys rights to Pfizer biosimilar

February 12, 2016
Medical Communications, Research and Development, Sales and Marketing Pfiizer, Sandoz, biosimilars

Sandoz has announced further expansion to its biosimilars programme with the acquisition of the European rights to Pfizer’s Remicade (infliximab) …

News
incyte

Incyte to stop Jakafi pancreatic, colorectal cancer drug trials

February 11, 2016
Research and Development Incyte, Jakafi, Jakavi, Novartis, Pancreatic cancer, colorectal cancer

Incyte said today that it is terminating its JANUS clinical trial programme testing blood cancer drug Jakafi in solid tumours …

News
abpi_logo

ABPI appoints Mike Thompson as new chief executive

February 11, 2016
Medical Communications

The Association of the British Pharmaceutical Industry (ABPI) has appointed former GlaxoSmithKline executive Mike Thompson as its new chief executive …

Appointment
gene

Genomics England enters bioinformatics partnership with Illumina

February 11, 2016
Research and Development Genomics england, Illumia

Genomics England has announced a new partnership with US-based sequencing specialist Illumina to develop a platform and knowledge base that …

News

Alzheimer’s disease market set to double to $10.4 Billion by 2021

February 11, 2016
Research and Development, Sales and Marketing Alzheimer's disease

The Alzheimer’s disease market will more than double from just under $5 billion in 2014 to an estimated $10.4 billion …

News
sandoz_building

EMA accepts Sandoz Neulasta biosimilar for review

February 11, 2016
Research and Development Amgen, Neulasta, Novartis, Sandoz

Sandoz says the European Medicines Agency (EMA) has accepted the marketing authorization application (MAA) for its proposed biosimilar to Amgen’s …

News
carol_lynch

Sandoz’s Carol Lynch elected to chair European Biosimilars Group

February 10, 2016
Medical Communications biosimilars

The European Generic Medicines Association (EGA) has elected Carol Lynch, global head of Biopharmaceuticals & Oncology Injectables at Sandoz, as …

Appointment
msd

MSD’s Zepatier approval could spell end of Gilead’s Hep C dominance, says analyst

February 10, 2016
Sales and Marketing AbbVie, Drug pricing, Gilead Sciences, MSD, Solvadi, Viekira Pak, harvoni, hepatitis C

The introduction of MSDs’ recently FDA-approved drug Zepatier (elbasvir/grazoprevir) to the hepatitis C treatment space will shake up a market …

News

NICE publishes new myeloma guidance

February 10, 2016
Medical Communications, Research and Development Farydak, Novartis, multiple myeloma

NICE has set out best practice for the diagnosis, monitoring and treatment of myeloma, in new guidelines published today. Myeloma …

News

Novartis says CDF proposals place “unreasonable” risk on pharma

February 10, 2016
Medical Communications, Research and Development, Sales and Marketing Cancer Drugs Fund, NHS England, NICE, Novartis

Novartis has criticised some of the proposed changes to the way in which the UK Cancer Drugs Fund (CDF) is …

News
heptares_logo

Heptares announces positive early-stage dementia trial results

February 10, 2016
Research and Development Alzheimer's, Alzheimers, Heptares, dementia, schizophrenia

Heptares has announced positive findings from its Phase 1b clinical study with its investigational drug HTL9936 as a treatment for …

News

FDA advisory committee recommends approval of Remicade biosimilar

February 10, 2016
Research and Development, Sales and Marketing FDA, Pfizer, Remicade, biosimilar, celltrion

An FDA advisory panel yesterday voted overwhelmingly in favour of approving CT-P13- Celltrion’s biosimilar version of Johnson&Johnson’s blockbuster arthritis drug …

News
cancer_cells_from_the_breast_cancer_now_tissue_bank_cell_programme

New breast cancer initiative brings together pharma and Europe’s top researchers

February 9, 2016
Medical Communications, Research and Development Pfizer, breast cancer

The UK charity Breast Cancer Now (BCN) has announced a new initiative seeking to bring together Europe’s top researchers and …

News
albert_bourla

Pfizer names leadership team post-Allergan merger

February 9, 2016
Manufacturing and Production, Sales and Marketing Allergan, Pfizer

Pfizer has announced the executive leadership team for the combined Pfizer and Allergan business once the $160 billiion merger deal …

Appointment
aedes_aegypti_mosquito

INTERVIEW: Tackling the Zika threat

February 9, 2016
Manufacturing and Production, Medical Communications Zika, vaccines

The Zika outbreak which started in Brazil and spread rapidly to other south American countries and beyond has taken the …

Feature
fda

FDA set to approve Remicade biosimilar

February 9, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Remicade, biosimilars, remsima

An FDA committee has had some positive words for Celltrion’s biosimilar candidate to Janssen/MSD’s Remicade (infliximab), concluding that the copycat biologic …

News

NICE changes mind on Amgen’s cholesterol drug

February 8, 2016
Manufacturing and Production, Sales and Marketing Amgen, NICE, Repatha

NICE has changed its mind on Amgen’s cholesterol-busting drug Repatha (evolocumab), and decided to recommend approval of the treatment in …

News
uganda_health_minister_sarah_opendi_at_merck_uganda_cancer_day

Merck partners with Ugandan Health Ministry to tackle cancer awareness

February 8, 2016
Manufacturing and Production, Medical Communications Africa, Cancer, Merck

Germany’s Merck celebrated World Cancer Day by collaborating with the Uganda Ministry of Health to raise awareness about early detection …

News
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026